Risk stratification based on screening history: The NELSON lung cancer screening study

Thorax

Volumn 72, Issue 9, 2017, Pages 819-824

  Yousaf Khan, Uraujh ^a   Van Der Aalst, Carlijn ^a   De Jong, Pim A ^b   Heuvelmans, Marjolein ^c   Scholten, Ernst ^b,d   Walter, Joan ^c   Nackaerts, Kristiaan ^e   Groen, Harry ^c   Vliegenthart, Rozemarijn ^c   Ten Haaf, Kevin ^a   Oudkerk, Matthijs ^c   De Koning, Harry ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Department of Orthopaedic Surgery   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Clinical Epidemiology; Lung Cancer; Smoking cessation; Tobacco and the lung

Indexed keywords

CIGARETTE SMOKE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SMOKING; ADVERSE EFFECTS; AGE; BELGIUM; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FOLLOW UP; LUNG NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; X-RAY COMPUTED TOMOGRAPHY;

AGE FACTORS; AGED; BELGIUM; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT; RISK FACTORS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85029385622     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-209892     Document Type: Article

References (28)

1. Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol 2016;893:1-19.
2. van Rens MT, Zanen P, Brutel de La Riviere A, et al. Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis. Chest 2000;118:952-8.
3. Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8.
4. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
5. Field JK, Duffy SW. Lung cancer CT screening: is annual screening necessary? Lancet Oncol 2016;5:543-4.
6. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): A prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50.
7. Patz EF Jr, Greco E, Gatsonis C, et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: A retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 2016;17:590-9.
8. Baldwin DR, Callister ME. What is the optimum screening strategy for the early detection of lung cancer. Clin Oncol 2016;28:672-81.
9. van der Aalst CM, Ten Haaf K, de Koning HJ. Lung cancer screening: latest developments and unanswered questions. Lancet Respir Med 2016;4:749-61.
10. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax 2012;67:296-301.
11. Wille MM, Dirksen A, Ashraf H, et al. Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J respire Crit Care Med 2016;193:542-51.
12. Infante M, Cavuto S, Lutman FR, et al. A randomized study of lung cancer screening with spiral computed tomography: Three-year results from the DANTE trial. Am J respire Crit Care Med 2009;180:445-53.
13. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15.
14. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74.
15. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
16. Yousaf-Khan U, van der Aalst C, de Jong PA, et al. Final screening round of the NELSON lung cancer screening trial: The effect of a 2.5-year screening interval. Thorax 2017;72:48-56.
17. Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in The National Lung Screening Trial. N Engl J Med 2013;369:920-31.
18. Aberle DR, Berg CD, Black WC, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53.
19. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: An individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6.
20. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011;103:1058-68.
21. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36.
22. Maisonneuve P, Bagnardi V, Bellomi M, et al. Lung cancer risk prediction to select smokers for screening CT-A model based on the Italian COSMOS trial. Cancer Prev Res 2011;4:1778-89.
23. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: Three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.
24. Walter JE, Heuvelmans MA, de Jong PA, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: Analysis of data from the randomised, controlled NELSON trial. Lancet Oncol 2016;17:907-16.
25. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-84.
26. Wang Y, van Klaveren RJ, van der Zaag-Loonen HJ, et al. Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program. Radiology 2008;248:625-31.
27. Xie X, Zhao Y, Snijder RA, et al. Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16-And 64-row multi-detector CT: An anthropomorphic phantom study. Eur Radiol 2013;23:139-47.
28. Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: A prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.